Cyclosporin and Plasmapheresis in Treatment of Progressive Systemic Lupus Erythematosus (pSLE)

By Schiel R.   Bambauer R.   Latza R.   Klinkmann J.  

Transfusion Science, Vol. 18, Iss. 1, 1997-03 ,pp. : 91-97

Elsevier

Access to resources Recommend Favorite

Autoimmunity to the p53 Protein is a Feature of Systemic Lupus Erythematosus (SLE) Related to Anti-DNA Antibodies

By Herkel J.   Mimran A.   Erez N.   Kam N.   Lohse A.W.   Märker-Hermann E.   Rotter V.   Cohen I.R.  

Journal of Autoimmunity, Vol. 17, Iss. 1, 2001-08 ,pp. : 63-69

Academic Press

Access to resources Recommend Favorite

Systemic Lupus Erythematosus: Current State of Diagnosis and Treatment

By  

Comprehensive Therapy, Vol. 32, Iss. 3, 2006-09 ,pp. : 158-162

Humana Press, Inc

Access to resources Recommend Favorite

Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE)

By Bonelli Michael   Savitskaya Anastasia   von Dalwigk Karolina   Steiner Carl Walter   Aletaha Daniel   Smolen Josef S.   Scheinecker Clemens  

International Immunology, Vol. 20, Iss. 7, 2008-07 ,pp. : 861-868

Oxford University Press

Access to resources Recommend Favorite

Comparison of the Anti-laminin Antibody Response in Patients with Systemic Lupus Erythematosus (SLE) and Parasitic Diseases (Filariasis)

By Lerma J.G.G.   Moneo I.   de Landázuri M.O.   Navarro J.S.  

Clinical Immunology, Vol. 76, Iss. 1, 1995-07 ,pp. : 19-31

Academic Press

Access to resources Recommend Favorite